期刊文献+

头孢替安对比头孢呋辛治疗泌尿系统感染的疗效研究 被引量:3

Study on the effect of cefotiam contrasted with cefuroxim in the treatment of urinary tract infection
下载PDF
导出
摘要 目的:比较头孢替安与头孢呋辛治疗泌尿系统感染的临床疗效、不良反应发生率及血清白介素-4(IL-4)、白介素-6(IL-6)、白介素-8(IL-8)浓度变化。方法:2018年1月-2020年6月收治泌尿系统感染患者130例,随机分为两组,各65例。对照组给予头孢呋辛治疗,观察组给予头孢替安治疗,比较两组治疗效果。结果:观察组治愈率显著高于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05);观察组治疗后IL-4、IL-6、IL-8水平均显著低于对照组,差异有统计学意义(P<0.05)。结论:头孢替安治疗泌尿系统感染的临床疗效优于头孢呋辛,可有效降低炎症因子水平,且安全性好。 Objective:To compare the clinical efficacy and incidence of adverse reactions of cefotiam and cefuroxime in the treatment of urinary tract infection,and the changes of serum IL-4,IL-6 and IL-8 levels before and after treatment.Methods:From January 2018 to June 2020,130 cases of patients with urinary system infection were enrolled,they were randomly divided into two groups with 65 cases in each group.The control group was given cefuroxime.The observation group was treated with cefotiam.The therapeutic effects between the two groups was compared.Results:The cure rate of the observation group was significantly higher than that of the control group,the difference was statistically significant(P<0.05).The incidence of adverse reactions between the two groups was compared,the difference was not statistically significant(P>0.05).After treatment,the IL-4,IL-6 and IL-8 levels in the observation group were significantly lower than those in the control group,the differences were statistically significant(P<0.05).Conclusion:The clinical effect of cefotiam is better than cefuroxime,which can effectively reduce inflammatory factor level and has high safety.
作者 朱东芳 Zhu Dongfang(The Maternal and Child Care Service Hospital of Changping District,Beijing City,Beijing 102200)
出处 《中国社区医师》 2021年第21期74-75,共2页 Chinese Community Doctors
关键词 头孢替安 头孢呋辛 泌尿系统感染 炎症反应 Cefotiam Cefuroxime Urinary system infection Inflammatory response
  • 相关文献

参考文献7

二级参考文献39

  • 1张艳文.加替沙星与左氧氟沙星分别应用于尿路感染治疗中的效果观察[J].医学信息,2017,30(7):94-95. 被引量:3
  • 2张景琼,张小文.高血压病患者睡眠质量与焦虑抑郁情绪的相关性研究[J].中国健康心理学杂志,2006,14(1):117-119. 被引量:55
  • 3李淑凤.影响慢性阻塞性肺疾病患者再人院的因素分析[J].中外健康文摘,2007,4(10):1-2. 被引量:4
  • 4中华人民共和国卫生部.医院感染诊断标准[M].3版.北京:中华人民共和国卫生部,2001. 被引量:1
  • 5Wang H,Chen M,Xu Y,et al.Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia:report from the communityacquired respiratory tract inrefection pathogen surveillance(CARTIPS)study,2009-2010[J].Int J Antimicrob Agents,2011,38(5):376-383. 被引量:1
  • 6Wang H,Zhao C,He W,et al.High prevalence of fluoroquinolone-resistant group B Streptococci among clinical isolates in China and predominance of sequence type 19with serotypeⅢ[J].Antimicrob Agents Chemother,2013,57(3):1538-1541. 被引量:1
  • 7alik S,Willby M,Sikes D,et al.New insights into fluoroquinolone resistance in Mycobacterium tuberculosis:functional genetic analysis of gyr A and gyr B mutations[J].PloS One,2012,7(6):e39754. 被引量:1
  • 8Matthews SJ,Lancaster JW.Urinary tract infections in the elderly population[J].Am J Geriatr Pharmacother,2011,9(5):286-309. 被引量:1
  • 9Choi GE,Shin SJ,Won CJ,et al.Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance[J].Am J Respir Crit Care Med,2012,186(9):917-925. 被引量:1
  • 10Bryant JM,Grogono DM,Greaves D,et al.Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis:a retrospective cohort study[J].Lancet,2013,381(9877):1551-1560. 被引量:1

共引文献5879

同被引文献40

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部